Taken together, these findings suggest that FMRP acts via BK channels in the hippocampus and other brain regions, and that the functional alteration of these channels may result in an abnormally high neurotransmitter release contributing to the synaptic alteration in FXS. This evidence concerns the gene FMR1 and fragile X syndrome.